🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Florence Guida

ORCID: 0000-0002-9652-2430

Also affiliated with Centre International de Recherche en Infectiologie, Centre international de recherche sur le cancer

MedicineEnvironmental ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor Expression”.

IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor Expression

medRxiv(2021)10.1101/2021.03.26.21254400

N/A

0DataRank · unranked

2 citations

Yan Chen, Linda Kachuri, Pooja Middha, Florence Guida, Hana Zahed +22 more

Global and regional estimates of orphans attributed to maternal cancer mortality in 2020

Nature Medicine(2022)10.1038/s41591-022-02109-2

N/A

0DataRank · unranked

181 citations

Rachel Kidman, Jacques Ferlay, Joachim Schüz, Isabelle Soerjomataram, Benda Kithaka +12 more

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Annals of Epidemiology(2022)10.1016/j.annepidem.2022.10.014

N/A

0DataRank · unranked

32 citations

Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed +51 more

Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1033

N/A

0DataRank · unranked

14 citations

Agustin Cerani, Florence Guida, Sirui Zhou, Antonio Agudo, Krasimira Aleksandrova +28 more

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

medRxiv(2022)10.1101/2022.03.21.22272544

N/A

0DataRank · unranked

3 citations

Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed +50 more

The blood proteome of imminent lung cancer diagnosis

Nature Communications(2023)10.1038/s41467-023-37979-8

N/A

0DataRank · unranked

79 citations

Karine Alcala, Nicolas Alcala, Christopher I. Amos, Alan A. Arslan, Julie K. Bassett +33 more

Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad071

N/A

0DataRank · unranked

23 citations

Wendy Wu, Justina Ucheojor Onwuka, Z. Haider, Karine Alcala, Karl Smith‐Byrne +33 more

Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis

EBioMedicine(2023)10.1016/j.ebiom.2023.104623

N/A

0DataRank · unranked

3 citations

David C. Muller, Hana Zahed, Karine Alcala, Florence Guida, Karl Smith-Byrne +16 more